Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMO | O15229 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 3/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.33 |
| ▸ | EGFR | P00533 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | DHODH | Q02127 | 2/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.31 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.31 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19139313 | 0.90 | MAPT (0.39) | MAPTSMN1; SMN2EGFRALDH1A1TDP1 | |
| SCHEMBL25454227 | 0.82 | MAPT (0.35) | MAPTSMN1; SMN2ALDH1A1TDP1LMNA | |
| SCHEMBL19142681 | 0.82 | SMN1; SMN2 (0.36) | MAPTSMN1; SMN2ALDH1A1 | |
| SCHEMBL22328707 | 0.81 | CES2 (0.37) | MAPTSMN1; SMN2ALDH1A1LMNA | |
| SCHEMBL21725383 | 0.78 | NPC1 (0.51) | MAPT | |
| SCHEMBL23816806 | 0.77 | KMO (0.42) | KMOMAPTSMN1; SMN2EGFRALDH1A1 | |
| SCHEMBL25619821 | 0.76 | MAOA (0.38) | MAPTSMN1; SMN2ALDH1A1TDP1LMNA | |
| SCHEMBL24217454 | 0.76 | PDK2 (0.32) | MAPTALDH1A1 | |
| SCHEMBL21600414 | 0.76 | MAPT (0.43) | KMOMAPTSMN1; SMN2EGFRALDH1A1 | |
| SCHEMBL19142011 | 0.75 | MAPT (0.37) | MAPTSMN1; SMN2EGFRALDH1A1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170222158-A1 | ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE | SAMSUNG SDI CO., LTD. (KR) | 2017-08-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170222158-A1 | ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE | OCIAD2, OCIAD1, AOX1 | KMO 684/4885MAPT 2418/4885SMN1; SMN2 4752/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.